Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03778528 · ClinicalTrials.gov registry record
Evaluation of Ocular Lens Proteins in Cataract From Individuals With Down Syndrome
A clinical trial, sponsored by University of Colorado, Denver.
- Terminated
- Registry status
- 1
- Enrollment target
NCT03778528: Clinical Trial study, sponsored by University of Colorado, Denver.
NCT03778528 is a clinical trial that was terminated before completion, run by University of Colorado, Denver. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03778528 was terminated before completion, sponsored by University of Colorado, Denver.
- TERMINATED
- Registry status
- 1 participants
- Enrollment target
Study Summary
This study involves the collection ocular lens tissue from individuals with Down syndrome and age-matched controls at the time of cataract surgery.
Primary Outcome
western blot analysis of proteins from cataractous tissue
Interventions
- PROCEDURE cataract surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2018-05-30 |
| Est. Completion | 2020-07-01 |
Why NCT03778528 stopped before completion
NCT03778528 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 1 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which cataract surgery is the first listed.
NCT03778528 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03778528 about?
NCT03778528 is a clinical study titled "Evaluation of Ocular Lens Proteins in Cataract From Individuals With Down Syndrome". This study involves the collection ocular lens tissue from individuals with Down syndrome and age-matched controls at the time of cataract surgery.
What is the current status of trial NCT03778528?
This trial is currently terminated. The enrollment target is 1 participants. The study started on 2018-05-30. Estimated completion is 2020-07-01.
What interventions are being tested in trial NCT03778528?
The interventions under investigation include: cataract surgery (PROCEDURE).
Who is sponsoring clinical trial NCT03778528?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI